2024-09-18 11:26:07
Gavi, the Vaccine Alliance, and Bavarian Nordic, the laboratory that produces the MPOX vaccine, signed an agreement on Wednesday, September 18, guaranteeing the supply in 2024 of 500,000 doses of the serum to African countries hit by an epidemic.
The MVA-BN vaccine “received WHO prequalification on September 13 and Bavarian Nordic will be ready to supply the vaccines pending the signing of a supply agreement with UNICEF [l’agence de l’ONU pour l’enfance]a partner of the Gavi alliance, which will deliver these doses”evokes a joint statement.
Read also | Mpox in the Democratic Republic of Congo: the response is being reorganized
Add to your selections
Separately, the Global Fund, a global public-private partnership that fights AIDS, tuberculosis and malaria, among other things, announced the payment of $9.5 million (some €8.5 million) to the Democratic Republic of Congo (DRC), considered the epicentre of the current mpox epidemic.
These funds are to help the DRC authorities carry out their “emergency response” in the hardest-hit regions of the country. The DRC had nearly 22,000 cases by the end of August and more than 700 deaths recorded since January, according to local authorities.
Elsewhere, mpox was present in 14 countries including Burundi, Congo-Brazzaville and the Central African Republic at the end of August, according to the Africa CDC, the Africa Centre for Disease Control.
Reuse this content
1727031140
#Agreement #supply #doses #MPOX #vaccine #Africa
